ACAA1
Basic information
Region (hg38): 3:38103129-38137242
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACAA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 32 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 2 | 1 |
Variants in ACAA1
This is a list of pathogenic ClinVar variants found in the ACAA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-38107585-T-C | not specified | Uncertain significance (Jun 13, 2022) | ||
3-38107606-G-T | not specified | Uncertain significance (Nov 03, 2023) | ||
3-38107664-T-G | not specified | Uncertain significance (Aug 13, 2021) | ||
3-38107708-C-T | not specified | Uncertain significance (Nov 15, 2024) | ||
3-38108411-G-A | not specified | Uncertain significance (Apr 26, 2024) | ||
3-38108452-A-T | Benign (Aug 17, 2018) | |||
3-38108478-A-T | not specified | Uncertain significance (Jul 16, 2024) | ||
3-38108504-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
3-38108514-A-G | not specified | Uncertain significance (Jan 29, 2024) | ||
3-38110166-A-G | not specified | Uncertain significance (Nov 10, 2024) | ||
3-38110169-C-T | Likely benign (May 01, 2022) | |||
3-38110170-G-A | not specified | Uncertain significance (Sep 11, 2024) | ||
3-38110179-G-A | not specified | Uncertain significance (Sep 09, 2024) | ||
3-38110199-C-T | not specified | Likely benign (Aug 21, 2024) | ||
3-38110211-C-T | not specified | Uncertain significance (Sep 09, 2021) | ||
3-38110217-C-T | not specified | Uncertain significance (May 13, 2024) | ||
3-38110223-T-C | not specified | Uncertain significance (Jul 10, 2024) | ||
3-38110235-G-C | not specified | Uncertain significance (Sep 10, 2024) | ||
3-38110244-G-A | not specified | Uncertain significance (Mar 29, 2022) | ||
3-38111681-A-G | Benign (Apr 03, 2018) | |||
3-38112270-A-G | not specified | Uncertain significance (Oct 06, 2021) | ||
3-38112275-A-G | not specified | Uncertain significance (May 30, 2023) | ||
3-38112335-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
3-38112352-C-A | Likely benign (Sep 01, 2022) | |||
3-38112369-T-C | Benign (Apr 03, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACAA1 | protein_coding | protein_coding | ENST00000333167 | 12 | 34114 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.59e-9 | 0.544 | 125667 | 0 | 81 | 125748 | 0.000322 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.22 | 195 | 249 | 0.783 | 0.0000134 | 2703 |
Missense in Polyphen | 73 | 98.717 | 0.73948 | 1025 | ||
Synonymous | -0.646 | 108 | 99.8 | 1.08 | 0.00000555 | 899 |
Loss of Function | 1.14 | 16 | 21.7 | 0.736 | 0.00000121 | 232 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000238 | 0.000238 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000710 | 0.000707 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000192 | 0.000185 |
Middle Eastern | 0.000710 | 0.000707 |
South Asian | 0.00114 | 0.00108 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Pathway
- Peroxisome - Homo sapiens (human);Biosynthesis of unsaturated fatty acids - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);alpha-Linolenic acid metabolism - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Valine, leucine and isoleucine degradation - Homo sapiens (human);PPAR Alpha Pathway;Nuclear Receptors Meta-Pathway;Amino Acid metabolism;PPAR signaling pathway;Neutrophil degranulation;Metabolism of lipids;alpha-linolenic acid (ALA) metabolism;Metabolism of proteins;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Tyrosine metabolism;Leukotriene metabolism;Omega-3 fatty acid metabolism;Saturated fatty acids beta-oxidation;Trihydroxycoprostanoyl-CoA beta-oxidation;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Innate Immune System;Immune System;Metabolism;Peroxisomal protein import;Fatty acid metabolism;Propanoate metabolism;Mono-unsaturated fatty acid beta-oxidation;Omega-6 fatty acid metabolism;Bile acid biosynthesis;Di-unsaturated fatty acid beta-oxidation;Phytanic acid peroxisomal oxidation;fatty acid β-oxidation (peroxisome);TYSND1 cleaves peroxisomal proteins;fatty acid β-oxidation;Valine Leucine Isoleucine degradation
(Consensus)
Recessive Scores
- pRec
- 0.695
Intolerance Scores
- loftool
- 0.134
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.85
Haploinsufficiency Scores
- pHI
- 0.0713
- hipred
- N
- hipred_score
- 0.338
- ghis
- 0.535
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.667
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acaa1b
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- very long-chain fatty acid metabolic process;protein targeting to peroxisome;fatty acid beta-oxidation;bile acid metabolic process;phenylacetate catabolic process;fatty acid beta-oxidation using acyl-CoA oxidase;alpha-linolenic acid metabolic process;neutrophil degranulation
- Cellular component
- extracellular region;peroxisome;peroxisomal matrix;cytosol;membrane;specific granule lumen;intracellular membrane-bounded organelle
- Molecular function
- acetyl-CoA C-acyltransferase activity;protein binding;acetate CoA-transferase activity;palmitoyl-CoA oxidase activity